Owens & Minor, Inc.
General ticker "OMI" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $1.0B
Owens & Minor, Inc. does not follow the US Stock Market performance with the rate: -22.6%.
Estimated limits based on current volatility of 3.4%: low 12.22$, high 13.09$
Factors to consider:
- US accounted for 97.3% of revenue in the fiscal year ended 2023-12-31
- Current price 18.2% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [15.31$, 29.21$]
- 2024-12-30 to 2025-12-30 estimated range: [18.96$, 34.31$]
Financial Metrics affecting the OMI estimates:
- Negative: Operating profit margin, % of 1.01 <= 1.03
- Positive: 0.93 < Non-GAAP EPS, $ of 1.36
- Positive: Operating cash flow per share per price, % of 46.14 > 12.76
- Negative: negative Net income
- Positive: -3.48 < Investing cash flow per share, $ of -1.81
- Positive: 1.31 < Industry earnings per price (median), % of 1.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term OMI quotes
Long-term OMI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $9,791.51MM | $9,960.73MM | $10,327.04MM |
| Operating Expenses | $9,423.03MM | $9,817.81MM | $10,222.53MM |
| Operating Income | $368.47MM | $142.91MM | $104.51MM |
| Non-Operating Income | $-91.72MM | $-132.02MM | $-159.23MM |
| Interest Expense | $48.09MM | $128.89MM | $157.91MM |
| R&D Expense | $12.10MM | $11.80MM | $0.00MM |
| Income(Loss) | $276.75MM | $10.89MM | $-54.73MM |
| Taxes | $55.16MM | $-11.50MM | $-13.43MM |
| Profit(Loss) | $221.59MM | $22.39MM | $-41.30MM |
| Stockholders Equity | $938.50MM | $945.60MM | $924.17MM |
| Inventory | $1,495.97MM | $1,333.59MM | $1,110.61MM |
| Assets | $3,536.55MM | $5,386.28MM | $5,093.32MM |
| Operating Cash Flow | $124.18MM | $325.01MM | $740.71MM |
| Capital expenditure | $49.69MM | $166.58MM | $207.89MM |
| Investing Cash Flow | $-53.63MM | $-1,804.48MM | $-137.25MM |
| Financing Cash Flow | $-129.48MM | $1,497.11MM | $-417.33MM |
| Earnings Per Share* | $3.05 | $0.30 | $-0.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.